Chronic Lymphocytic Leukemia

FDA Clears clonoSEQ Assay to Evaluate MRD in Patients with CLL
August 07, 2020

The FDA cleared the clonoSEQ assay to detect and monitor minimal residual disease in blood or bone marrow from patients with chronic lymphocytic leukemia.

Matthew Steven Davids, MD, MMSc, on the Venetoclax, R-EPOCH Combo for Richter’s Syndrome
July 26, 2020

The CLL expert spoke about the implications of this study for patients and how patients can apply this knowledge to their own course of treatment.

Matthew Steven Davids, MD, MMSc on Venetoclax Plus R-EPOCH in Hematologic Cancers
July 11, 2020

The chronic lymphocytic leukemia expert spoke about the possible use of venetoclax plus dose-adjusted R-EPOCH in various hematologic patient populations.